Article thumbnail

Effect of Resident Physician Education Regarding Selective Chemoprophylaxis for the Prevention of Early Onset Group B Streptococcal Sepsis: An Outcome Study

By Jeffrey S. Greenspoon, Doron J. D. Rosen and Anita P. Sumen


Objective: The aim of this study was to evaluate the effect of a voluntary protocol for selective intrapartum chemoprophylaxis on the incidence of early onset group B streptococcal sepsis (GBS EOS)

Topics: Research Article
Publisher: Hindawi Publishing Corporation
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (1990). (eds): Goodman and Gilman’s The Pharmacological Basis ofTherapeutics. 8th Ed.
  2. (1992). American College of Obstetrics and Gynecology: Group B Streptococcal Infections in Pregnancy.
  3. (1986). An obstetric approach to the prevention of early-onset group B beta-hemolytic streptococcal sepsis.
  4. (1992). Assessment of rapid identification tests for genital carriage of group B streptococci. Obstet Gynecol 80:1038-1047,
  5. (1992). Committee on Infectious Diseases and Committee on Fetus and Newborn: Guidelines for prevention of group B streptococcal (GBS) infection by chemoprophylaxis. Pediatrics
  6. (1993). CV: Comparison of prevention strategies for neonatal group B streptococcal infection: A population-based economic analysis.
  7. (1991). Fliegner JR: Group B Streptococcus (GBS) and neonatal infections: The case for intrapartum prophylaxis.
  8. (1983). Gotoff SP: Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. I. Epidemiologic rationale.
  9. (1983). Gotoff SP: Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. II. Predictive value of prenatal cultures.
  10. (1983). Gotoff SP: Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. III. Interruption of motherto-infant transmission, j Infect Dis 148:810-816,
  11. GotoffSP: Prevention ofearly-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis.
  12. (1991). Greenspoon RL, Lewis W: Comparison of culture for group B Streptococcus versus enzyme immunoassay and latex agglutination rapid tests: Results in 250 patients during labor. Obstet Gyneco177:97-100,
  13. (1990). Hankins GDV: Cost-effectiveness of intrapartum screening and treatment for maternal group B streptococci colonization.
  14. (1978). Hobel CJ: Epidemiology of group B Streptococcus: Longitudinal observations during pregnancy.
  15. IJ: Early onset group B streptococcal disease: Clinical, roentgenographic, and pathologic features.
  16. MJ: Confidence Interval Analysis (CIA). Version 1.0. Br Med J
  17. NelsonJD: Consensus: Perinatal prophylaxis for group B streptococcal infection.
  18. (1991). Nugent RP for the Vaginal Infection and Prematurity Study Group: The epidemiology of group B streptococcal colonization in pregnancy.
  19. (1991). PhillipsCF (eds): Group B Streptococcal Infections. Report of the Committee on Infectious Diseases. 22nd Ed. Elk Grove Village, IL: American Academy ofPediatrics,
  20. (1993). RS: Adverse perinatal outcome and resistant Enterobacteriaceae after antibiotic usage for premature rupture of the membranes and group B Streptococcus carriage. Obstet Gynecol 82:487-489,
  21. (1991). TH: Group B Streptococcus: The effectiveness of screening and chemoprophylaxis. Obstet Gynecol Surv 46:499-508,
  22. (1988). When to treat intra-amniotic infection (editorial).